BIIB

BIIB Other Current Assets

$1.75BQuarterly · USD

Period ending:

BIIB FY Other Current AssetsUSD
BIIB FY Other Current Assets1985-12-31: $1.30M1986-12-31: $1.40M1987-12-31: $700.00K1988-12-31: $1.70M1989-12-31: $80.60M1990-12-31: $95.00M1991-12-31: $134.20M1992-12-31: $149.10M1993-12-31: $203.20M1994-12-31: $8.48M1995-12-31: $12.75M1996-12-31: $23.53M1997-12-31: $31.97M1998-12-31: $49.37M1999-12-31: $67.76M2000-12-31: $62.63M2001-12-31: $77.93M2002-12-31: $50.96M2003-12-31: $828.94M2004-12-31: $171.60M2005-12-31: $108.38M2006-12-31: $101.42M2007-12-31: $355.19M2008-12-31: $155.89M2009-12-31: $162.02M2010-12-31: $203.62M2011-12-31: $144.60M2012-12-31: $136.01M2013-12-31: $226.13M2014-12-31: $447.46M2015-12-31: $836.90M2016-12-31: $1.09B2017-12-31: $962.00M2018-12-31: $958.80M2019-12-31: $631.00M2020-12-31: $881.10M2021-12-31: $740.80M2022-12-31: $1.42B2023-12-31: $1.18B2024-12-31: $752.50M2025-12-31: $1.12B$1.42B$0.00
1985-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

BIIB other current assets history

Current assets not classified elsewhere. The available annual fiscal periods series contains 41 observations from Dec 31, 1985 to Dec 31, 2025.

Biogen Other Current Assets — Annual fiscal periods (USD)
Period endingOther Current Assets (USD)
1,123,300,000
752,500,000
1,182,000,000
1,417,600,000
740,800,000
881,100,000
631,000,000
958,800,000
962,000,000
1,093,300,000
836,900,000
447,462,000
226,134,000
136,011,000
144,600,000
203,622,000
162,024,000
155,891,000
355,185,000
101,419,000
108,375,000
171,598,000
828,941,000
50,963,000
77,930,000
62,634,000
67,759,000
49,365,000
31,973,000
23,533,000
12,749,000
8,480,000
203,200,000
149,100,000
134,200,000
95,000,000
80,600,000
1,700,000
700,000
1,400,000
1,300,000

Compare other current assets

All BIIB financial metrics · BIIB stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.